Staphylococcus aureus corneal infections: Effect of the Panton-Valentine Leukocidin (PVL) and antibody to PVL on virulence and pathology

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 7, 2013, Pages 4430-4438

  Zaidi, Tanweer ^a   Zaidi, Tauqeer ^a   Yoong, Pauline ^a,b   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Keratitis; MRSA; PVL

Indexed keywords

BACTERIUM ANTIBODY; LACTATE DEHYDROGENASE; PANTON VALENTINE LEUKOCIDIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL KERATITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY TEST; FEMALE; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS INFECTION;

ANTIBODY; KERATITIS; MRSA; PVL;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CORNEA; DISEASE MODELS, ANIMAL; EXOTOXINS; EYE INFECTIONS, BACTERIAL; FEMALE; KERATITIS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED A; STAPHYLOCOCCAL INFECTIONS; VIRULENCE;

EID: 84879571880     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11701     Document Type: Article

References (47)

1. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillinresistant Staphylococcus aureus. Am J Ophthalmol. 2007;144: 313-315
2. Asbell PA, Sahm DF, Shaw M, Draghi DC, Brown NP. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34:814-818
3. Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W. Update on bacterial conjunctivitis in South Florida. Ophthalmology. 2008;115:51-56
4. Chisari G, Accossano S, Reibaldi M. Effect of aminoglycosides (sub-MICs) on adherence of coagulase-negative staphylococci to intraocular lens surface. J Chemother. 2002;14:574-578
5. Manzur A, Vidal M, Pujol M, et al. Predictive factors of methicillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect. 2007;66:135-141
6. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-1771
7. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13:1840-1846
8. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315:1130-1133
9. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006;194:1761-1770
10. Bubeck Wardenburg J, Palazzolo-Ballance M, Otto M, Schneewind O, DeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of communityassociated methicillin-resistant Staphylococcus aureus disease. J Infect Dis. 2008;198:1166-1170
11. Brown EL, Bowden MG, Bryson RS, et al. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol. 2009;16:139-141
12. Tseng CW, Kyme P, Low J, et al. Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS ONE. 2009;4:e6387
13. Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A. 2010;107:2241-2246
14. Yoong P, Pier GB. Immune-activating properties of Panton- Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun. 2012;80:2894-2904
15. Nadig S, Velusamy N, Lalitha P, Kar S, Sharma S, Arakere G. Staphylococcus aureus eye infections in two Indian hospitals: emergence of ST772 as a major clone. Clin Ophthalmol. 2012; 6:165-173
16. Rutar T, Chambers HF, Crawford JB, et al. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006;113:1455-1462
17. Lipinska U, Hermans K, Meulemans L, et al. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One. 2011;6: e22864
18. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A. 2010;107:5587-5592
19. Otto M. Basis of virulence in community-associated methicillin- resistant Staphylococcus aureus. Annu Rev Microbiol. 2010;64:143-162
20. Li M, Cheung GY, Hu J, et al. Comparative analysis of virulence and toxin expression of global community-associated methicillin- resistant Staphylococcus aureus strains. J Infect Dis. 2010;202:1866-1876
21. Kaneko J, Kamio Y. Bacterial two-component and heteroheptameric pore-forming cytolytic toxins: structures, poreforming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004;68:981-1003
22. Konig B, Prevost G, Piemont Y, Konig W. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis. 1995;171:607-613
23. Konig B, Prevost G, Konig W. Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J Med Microbiol. 1997;46:479-485
24. Hazlett LD. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm. 2005;13: 133-138
25. Johnson AC, Heinzel FP, Diaconu E, et al. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci. 2005;46:589-595
26. Kumar A, Hazlett LD, Yu FS. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun. 2008;76:89-96
27. Gadjeva M, Nagashima J, Zaidi T, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog. 2010;6:e1000826
28. Hermos CR, Yoong P, Pier GB. High levels of antibody to Panton-Valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis. 2010;51:1138-1146
29. Preston MJ, Fleiszig SMJ, Zaidi TS, et al. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun. 1995; 63:3497-3501
30. Zaidi TS, Preston MJ, Pier GB. Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection. Infect Immun. 1997;65:1370-1376
31. Zaidi TS, Lyczak J, Preston M, Pier GB. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect Immun. 1999;67:1481-1492
32. Konig B, Koller M, Prevost G, et al. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin- 8. Infect Immun. 1994;62:4831-4837
33. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44:108-118
34. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillinresistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol. 2010;125:39-49
35. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984
36. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132
37. Campbell SJ, Deshmukh HS, Nelson CL, et al. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol. 2008;46:678-684
38. Lalani T, Federspiel JJ, Boucher HW, et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol. 2008;46:2890-2896
39. Bae I-G, Tonthat GT, Stryjewski ME, et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol. 2009;47:3952-3957
40. Campo M, Hachem R, Jiang Y, et al. Panton Valentine leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Medicine (Baltimore). 2011;90:312-318
41. Peyrani P, Allen M, Wiemken TL, et al. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis. 2011;53:766-771
42. Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:43-54
43. Hensler T, König B, Prévost G, Piémont Y, Köller M, König W. Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun. 1994;62: 2529-2535
44. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun. 2002;70:2187-2197
45. Chusid MJ, Nelson DB, Meyer LA. The role of the polymorphonuclear leukocyte in the induction of corneal edema. Invest Ophthalmol Vis Sci. 1986;27:1466-1469
46. Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007;84:273-278
47. Zaidi TS, Zaidi T, Pier GB. Role of neutrophils, MyD88- mediated neutrophil recruitment and complement in antibody- mediated defense against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2009;51:2085-2093.